Do reductions in risk of cardiorenal events with SGLT2 inhibitors in type 2 diabetes vary with baseline characteristics? A meta-analysis

Affiliations

• ¹ Department of General Medicine, Guangdong Medical University Affiliated Longhua Central Hospital, Shenzhen, China.
• ² Department of Endocrinology, Second Affiliated Hospital of Kunming Medical University, Kunming, China.
• ³ Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
• ⁴ Department of General Medicine, The Central Hospital of Tuoshi Town, Tianmen, China.
• ⁵ Department of Nephrology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
• ⁶ Department of Endocrinology, Guangdong Medical University Affiliated Longhua Central Hospital, Shenzhen, China. 15887847798m0@sina.cn.